Hemostatic Efficacy of EVARREST™, Fibrin Sealant Patch vs. TachoSil® in a Heparinized Swine Spleen Incision Model

REFERENCES

• Holcomb JB. Optimal use of blood products in severely injured trauma patients. Hematol Am Soc Hematol Educ Program. 2010;2010:465–469.
   PubMed Web of Science ®Google Scholar
• Maisano F, Kjaergård HK, Bauernschmitt R, TachoSil surgical patch versus conventional haemostatic fleece material for control of bleeding in cardiovascular surgery: a randomised controlled trial. Eur J Cardiothorac Surg. 2009;36(4):708–714.
   PubMed Web of Science ®Google Scholar
• Frilling A, Stavrou GA, Mischinger H-J, Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomized prospective trial. Langenbecks Arch Surg. 2005;390(2):114–120.
   PubMed Web of Science ®Google Scholar
• Fischer L, Seiler CM, Broelsch CE, Hemostatic efficacy of TachoSil in liver resection compared with argon beam coagulator treatment: an open, randomized, prospective, multicenter, parallel-group trial. Surgery. 2011;149(1):48–55.
   PubMed Web of Science ®Google Scholar
• Siemer S, Lahme S, Altziebler S, Efficacy and safety of TachoSil as haemostatic treatment versus standard suturing in kidney tumour resection: a randomised prospective study. Eur Urol. 2007;52(4):1156–1163.
   PubMed Web of Science ®Google Scholar
• Carbon RT, Baar S, Waldschmidt J, Innovative minimally invasive pediatric surgery is of therapeutic value for splenic injury. J Pediatr Surg. 2002;37(8):1146–1150.
   PubMed Web of Science ®Google Scholar
• Seyednejad H, Imani M, Jamieson T, Topical haemostatic agents. Br J Surg. 2008;95(10):1197–1225.
   PubMed Web of Science ®Google Scholar
• Muench TR, Kong W, Harmon AM. The performance of a hemostatic agent based on oxidized regenerated cellulose –polyglactin 910 composite in a liver defect model in immunocompetent and athymic rats. Biomaterials. 2010;31(13):3649–3656.
   PubMed Web of Science ®Google Scholar
• Institute for Laboratory Animal Research. Guide for the Care and Use of Laboratory Animals, 8th ed.; The National Academies Press, Washington, DC, 2011. Available from: https://www.aaalac.org/resources/theguide.cfm
   Google Scholar
• Rickenbacher A, Breitenstein S, Lesurtel M, Efficacy of TachoSil a fibrin-based haemostat in different fields of surgery—a systematic review. Expert Opin Biol Ther. 2009;9(7):897–907.
   PubMed Web of Science ®Google Scholar
• Dalpiaz O, Neururer R, Bartsch G, Haemostatic sealants in nephron-sparing surgery: what surgeons need to know. BJU Int. 2008;102(11):1502–1508.
   PubMed Web of Science ®Google Scholar
• Pusateri AE, Modrow HE, Harris RA, Advanced hemostatic dressing development program: animal model selection criteria and results of a study of nine hemostatic dressings in a model of severe large venous hemorrhage and hepatic injury in swine. J Trauma. 2003;55(3):518–526.
   PubMedGoogle Scholar
• Pusateri AE, Holcomb JB, Kheirabadi BS, Making sense of the preclinical literature on advanced hemostatic products. J Trauma. 2006;60(3):674–682.
   PubMedGoogle Scholar
• Hutchinson RW, George K, Johns D, Hemostatic efficacy and tissue reaction of oxidized regenerated cellulose hemostats. Cellulose. 2013;20:537–545.
   Web of Science ®Google Scholar
• Berdajs D, Bürki M, Michelis A, Seal properties of TachoSil: in vitro hemodynamic measurements. Interact Cardiovasc Thorac Surg. 2010;10(6):910–913.
   PubMed Web of Science ®Google Scholar
• TachoSil Prescribing Information. Available from: http:// www.tachosil.com/howtoapply/illustrations. Cited Jan 1, 2014.
   Google Scholar
• Hutchinson RW, Broughton D, Barbolt TA, Hemostatic effectiveness of fibrin pad after partial nephrectomy in swine. J Surg Res. 2011;167(2):e291–e298.
   Web of Science ®Google Scholar
• Nativ O, Patel B, Shen, J, Safety and hemostatic efficacy of fibrin pad in partial nephrectomy: results of an open-label phase I and a randomized, standard-of-care-controlled phase I/II study BMC Nephrol. 2012 Nov8;13:147. doi: 10.1186/1471-2369-13-147.
   PubMed Web of Science ®Google Scholar
• Koea JB, Baldwin P, Hart J, Fischer CP, Garden OJ. A phase III, randomized, controlled, superiority study evaluating the fibrin pad versus standard of care treatment in controlling severe soft tissue bleeding during abdominal, retroperitoneal, pelvic, and thoracic surgery. Association of Surgeons of Great Britain and Ireland, International Surgical Congress, Expertise and Excellence, Liverpool, England, May 9–12, 2012, Abstract #0617.
   Google Scholar
• Koea JB, Batiller J, Patel B, A phase III, randomized, controlled, superiority trial evaluating the fibrin pad versus standard of care in controlling parenchymal bleeding during elective hepatic surgery. HPB. 2013;15:61–70.
   PubMed Web of Science ®Google Scholar
• Fischer CP, Bochicchio G, Batiller J, A prospective, radomized, controlled trial of the efficacy and safety of fibrin pad as an adjunct to control soft tissue bleeding during abdominal, retroperitoneal, pelvic, and thoracic surgery. J Am Coll Surg. 2013;217(3):385–933.
   PubMed Web of Science ®Google Scholar